Tracheal replacement for primary tracheal cancer.

Area of Science:

• Regenerative Medicine
• Biomaterials Science
• Surgical Innovation

Background:

• Tracheal defects pose significant clinical challenges.
• Conventional treatments like aortic homografts and allotransplantation have limitations.
• Allotransplantation necessitates lifelong immunosuppression, raising ethical concerns for non-life-saving procedures.

Purpose of the Study:

• To review and compare clinical methods for tracheal replacement.
• To evaluate conventional and tissue-engineered approaches.
• To highlight the pros and cons of each strategy.

Main Methods:

• Review of current clinical strategies for tracheal replacement.
• Analysis of aortic homografts, allotransplantation, and tissue engineering.
• Examination of tissue-engineered tracheal transplantation techniques.

Main Results:

• Tissue-engineered tracheal transplantation utilizes biological or bioartificial scaffolds.
• Scaffolds are reseeded with mesenchymal stromal cells and bioactive molecules.
• These approaches aim to enhance regeneration and promote neovascularization.

Conclusions:

• Tracheal tissue engineering presents a viable alternative to conventional allotransplantation.
• This approach shows promise for both adult and pediatric patients.
• Ongoing clinical investigations are evaluating various methods, with long-term outcomes pending.